PLoS Clinical Trials has merged with PLoS ONE
In September 2007, PLoS launched the PLoS Hub for Clinical Trials. All previously published articles from PLoS Clinical Trials are now included in the Hub, as well as relevant research from PLoS ONE, and in future, other PLoS journals. The PLoS Hub for Clinical Trials demonstrates our commitment to publishing the results of all properly conducted and reported clinical trials, and to making this essential information freely and publicly available.
Authors wishing to submit trials for publication should now submit to PLoS ONE, which has editorial goals closely matching the original aims of PLoS Clinical Trials; PLoS ONE aims to publish all research that is ethically conducted, technically sound and properly described. Authors publishing with PLoS ONE will benefit from very rapid publication (acceptance to publication in less than three weeks), and a more modest publication fee (US$1250). In addition to PLoS ONE, authors wishing to submit clinical trials can also consider other PLoS journals.
Users can now interact with clinical trials articles via the PLoS Hub, using the tools available for online annotation, discussion, and rating.
All previously registered users for PLoS Clinical Trials contents alerts will continue to receive e-mail alerts from the PLoS Hub for Clinical Trials. New users should sign up to receive alerts from the PLoS Hub for Clincal Trials via e-mail or an RSS feed.
We are grateful to the many community members who helped us to establish standards for clinical trials reporting in PLoS Clinical Trials, many of whom are also ensuring that the same standards are maintained in PLoS ONE.
All site content, except where otherwise noted, is licensed under a